Search results
Results from the WOW.Com Content Network
Hot flashes in males could have various causes. It can be a sign of low testosterone. [4] [5] [6] Males with prostate cancer or testicular cancer can also have hot flashes, especially those who are undergoing hormone therapy with antiandrogens, also known as androgen antagonists, which reduce testosterone to castrate levels. [7]
In a menopause Reddit thread, women described their hot flashes as making them feel "claustrophobic" and causing their blood pressure or heart rates to go up. One described a dizzy and feverish ...
“For alleviating hot flashes and night sweats, hormone therapy is the most effective option,” says Dr. Monica Christmas, MD, an OB/GYN and director of the Menopause Program with the University ...
Regurgitation and heartburn in pregnancy can be at least alleviated by eating multiple small meals a day, avoiding eating within three hours of going to bed, and sitting up straight when eating. [ 26 ] [ 27 ] If diet and lifestyle changes are not enough, antacids and alginates may be required to control indigestion, particularly if the symptoms ...
To many women, hot flashes "feel like a sudden rush of intense heat that starts in the chest and moves up into the neck and face," explains Dr. Ruta Nonacs, a perinatal and reproductive ...
In women, low levels of estrogen may cause symptoms such as hot flashes, sleeping disturbances, decreased bone health, [3] and changes in the genitourinary system. Hypoestrogenism is most commonly found in women who are postmenopausal , have primary ovarian insufficiency (POI), or are presenting with amenorrhea (absence of menstrual periods ).
A majority of women will get hot flashes at some point. Here's what to know about the symptoms, causes and treatments. Skip to main content. Subscriptions; Animals. Business. Entertainment ...
Fezolinetant, sold under the brand name Veozah among others, is a medication used for the treatment of hot flashes (vasomotor symptoms) due to menopause. [3] [9] It is a small-molecule, orally active, selective neurokinin-3 (NK 3) receptor antagonist which is under development by for the treatment of sex hormone-related disorders.